Cargando…
The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome
High-grade ovarian serous carcinomas (HGSC) are characterized by TP53 mutations and non-random patterns of chromosomal anomalies, where the nature of the TP53 mutation may correlate with clinical outcome. However, the frequency of common somatic genomic events occurring in HGSCs from demographically...
Autores principales: | Wojnarowicz, Paulina M., Oros, Kathleen Klein, Quinn, Michael C. J., Arcand, Suzanna L., Gambaro, Karen, Madore, Jason, Birch, Ashley H., de Ladurantaye, Manon, Rahimi, Kurosh, Provencher, Diane M., Mes-Masson, Anne-Marie, Greenwood, Celia M. T., Tonin, Patricia N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447752/ https://www.ncbi.nlm.nih.gov/pubmed/23029043 http://dx.doi.org/10.1371/journal.pone.0045484 |
Ejemplares similares
-
Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
por: Birch, Ashley H., et al.
Publicado: (2011) -
Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015) -
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
por: Cavallone, Luca, et al.
Publicado: (2008) -
Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease
por: Fleury, Hubert, et al.
Publicado: (2015) -
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity
por: Wojnarowicz, P, et al.
Publicado: (2012)